EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Association of Loop Diuretic Use with Hospitalization with Atrial Fibrillation in CKD

Katherine Scovner Ravi, Armida LeFranc Torres, Finnian R. Mc Causland

Kidney360 · 2026-10 · 7 (10) · 2274-2280

DOI: 10.34067/kid.0000001229 ↗
AbstractBibliografische Angaben

Abstract

Key Points The use of loop diuretic medications was associated with a 34% higher risk of hospitalization with atrial fibrillation in patients with CKD. The association appeared stronger in patients with comorbid heart failure compared with those without. Future research is indicated to explore mechanisms and mitigate potential harms. Background CKD is associated with a high burden of cardiovascular complications, including atrial fibrillation. While loop diuretic medications are commonly prescribed for volume and BP management in CKD, their relationship with incident atrial fibrillation in this population remains poorly understood. Methods Using data from 4607 patients without baseline atrial fibrillation from the Chronic Renal Insufficiency Cohort, we used adjusted Cox regression models to explore the association of baseline loop diuretic use with hospitalization with atrial fibrillation. We tested for differential associations according to sex, history of heart failure, and baseline CKD stage category. Models adjusted for demographics, cardiovascular risk factors, kidney function (eGFR), laboratory parameters (albumin, hematocrit, log 24-hour urine protein), and the use of cardiovascular medications. Results The mean age of subjects at baseline was 59±11 years, 44% were female, and 42% were Black. The mean follow-up was 9.3 years, during which time 614 participants experienced a hospitalization with atrial fibrillation. Baseline loop diuretic therapy was associated with a 41% higher risk of hospitalization with atrial fibrillation (adjusted hazard ratio [aHR], 1.41; 95% confidence interval [CI], 1.14 to 1.73). There was no effect modification by sex or CKD stage ( P interactions = 0.52 and 0.29, respectively). The association appeared stronger among those with versus without heart failure (aHR, 3.00; 95% CI, 1.22 to 7.37 versus aHR, 1.33; 95% CI, 1.06 to 1.66), although the interaction did not reach statistical significance ( P interaction = 0.06). Conclusions Among patients with CKD and without a history of atrial fibrillation, the use of loop diuretics is independently associated with subsequent hospitalization with atrial fibrillation. This association appeared to be more potent among those with (versus without) a history of heart failure. The etiology of the observed association requires further investigation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →